On 14 and 15 March, EMA held a workshop and a joint meeting of the Patients’ and Consumers’ Working Party (PCWP) and Healthcare Professionals’ Working Party (HCPWP) on personalised medicines, which included discussions on biosimilars and EU initiatives on HTA, among other topics.
ECPC, as accredited Member of the PCWP, expressed the cancer patients’ views and priorities on these issues, thanks to the participation of ECPC Vice-President Kathi Apostolidis and former ECPC Board Member and current Associate Consultant Rafal Swierzewski.
To check out more details about the workshop and joint meeting, click here and here.